Ardelyx Inc. (ARDX)

3.95 -0.3 (-7.059%)

IEX Real-Time Price

June 20, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 4.25

Price Open 4.25

Volume: 1.31M

Avg Volume: 1.02M

Market Cap: 237.41M

P/E Ratio -3.5

52 Wk Range 3.75-8.65



ARDX Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-05-31
58.51M
580,042
0.57
0.99%

2018-05-15
46.01M
1.31M
4.31
2.85%

2018-04-30
46.01M
1.34M
3.85
2.91%

2018-04-13
46.01M
1.41M
4.31
3.07%




ARDX Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-08
Q1 2018
N/A
-0.42 (2)
-0.36
0.06

2018-05-04
Q1 2018
N/A
-0.40 (2)
0.00
0.00

2018-03-16
Q4 2017
N/A
-0.39 (2)
0.00
0.00

2018-03-14
Q4 2017
N/A
-0.39 (2)
0.21
0.60

News

Your Daily Pharma Scoop: Recent IPO And Offerings Review (2018-05-31 04:02 SeekingAlpha)

IPO As a general rule, we dont invest in IPOs. It is too risky. What is an IPO but an unknown/unproven business asking for your money to chase some dream of theirs. But many people like dreams, so when an IPO gets launched - assuming theres enough hype - the stock soars f…

 

Ardelyx to Present at the Jefferies 2018 Global Healthcare Conference (2018-05-29 06:30 PR Newswire)

FREMONT, Calif. , May 29, 2018 /PRNewswire/ --Ardelyx, Inc. (NASDAQ: ARDX) today announced that Mike Raab , president and chief executive officer of Ardelyx, will present a company overview at the Jefferies Global Healthcare Conference on Tuesday, June 5, 2018 at 2:30 p.m. ET i…

 

Midday Gainers / Losers (05/23/2018) (2018-05-23 12:36 SeekingAlpha)

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more …

 

Premarket Losers as of 9:10 am (5/23/2018) (2018-05-23 09:17 SeekingAlpha)

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more …

 

Ardelyx down 9% on pricing common stock offering (2018-05-23 07:22 SeekingAlpha)

Ardelyx (NASDAQ: ARDX ) prices its public offering of 12.5M shares of common stock at a price of $4.00 per share yielding gross proceeds of $50M. More news on: Ardelyx, Healthcare stocks news, Stocks on the move, Read more …

 


Statistics

Shares Outstanding: 60.1M

Top 15 Institution Percent: 68.40

Price To Sales: 5.76

Price To Book: 1.98

Revenue: N/A

Gross Profit: N/A

Cash: 278.01M

Debt: N/A

Return On Assets: -29.63

Return On Equity: -33.03

Profit Margin: N/A

Price History

Beta: 0.77

50-day Moving Avg: 4.71

200-day Moving Avg: 5.64

YTD Change: -39.29

5-day Change: 5.59

1-month Change: -24.78

3-month Change: -20.56

6-month Change: -33.07

1-year Change: -8.60

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Ardelyx Inc.

Exchange: NASDAQ Global Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.ardelyx.com

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases.